ArticleFrontiers in immunology2022

Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.

Likun Luan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.